We are live on ! Find out more
FMA

FNY Managed Accounts Portfolio holdings

AUM $83.4M
1-Year Est. Return 11.55%
This Fund
S&P 500
This Quarter Est. Return
-1.59%
1 Year Est. Return
+11.55%
3 Year Est. Return
+14.73%
5 Year Est. Return
+155.96%
10 Year Est. Return
AUM
$14.9M
AUM Growth
-$103M
Cap. Flow
-$102M
Cap. Flow %
-682.87%
Top 10 Hldgs %
88.13%
Holding
441
New
17
Increased
9
Reduced
5
Closed
403

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 29.08%
2 Healthcare 28.95%
3 Technology 7%
4 Industrials 6.75%
5 Materials 4.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CS
301
DELISTED
Credit Suisse Group
CS
-27,500
Closed -$361K
DBD
302
DELISTED
Diebold Nixdorf Incorporated
DBD
-4,875
Closed -$121K
BBBY
303
CALL
DELISTED
Bed Bath & Beyond Inc
BBBY
-400
Closed -$16.3K
PLXP
304
DELISTED
PLx Pharma Inc. Common Stock
PLXP
-19
Closed -$2.17K
PRTY
305
DELISTED
Party City Holdco Inc.
PRTY
-100
Closed -$1.71K
CLVS
306
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
-169
Closed -$107K
CLVS
307
DELISTED
Clovis Oncology, Inc.
CLVS
-500
Closed -$18K
CLVS
308
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
-5
Closed -$1.44K
TWTR
309
CALL
DELISTED
Twitter, Inc.
TWTR
-1,145
Closed -$34.6K
TWTR
310
PUT
DELISTED
Twitter, Inc.
TWTR
-1,150
Closed -$21.6K
GBT
311
DELISTED
Global Blood Therapeutics, Inc.
GBT
-2,130
Closed -$49.1K
MNDT
312
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
-1,080
Closed -$13.3K
MNDT
313
DELISTED
Mandiant, Inc. Common Stock
MNDT
-35,600
Closed -$524K
RDUS
314
DELISTED
Radius Health, Inc.
RDUS
-5,500
Closed -$297K
SRRA
315
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-500
Closed -$36.4K
HSTO
316
CALL
DELISTED
Histogen Inc. Common Stock
HSTO
0
-$400
HSTO
317
DELISTED
Histogen Inc. Common Stock
HSTO
-135
Closed -$54K
HBP
318
DELISTED
Huttig Building Products, Inc.
HBP
-3,498
Closed -$20.2K
XLNX
319
CALL
DELISTED
Xilinx Inc
XLNX
-140
Closed -$13.1K
RDS.A
320
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-5,500
Closed -$275K
SQBG
321
DELISTED
Sequential Brands Group, Inc.
SQBG
-38
Closed -$12K
CLGX
322
DELISTED
Corelogic, Inc.
CLGX
-2,000
Closed -$78.4K
GWPH
323
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
-2,375
Closed -$315K
GWPH
324
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
-10
Closed -$3.1K
IPHI
325
DELISTED
INPHI CORPORATION
IPHI
-15,254
Closed -$664K

Similar funds

FNY Managed Accounts's Q4 2016 Portfolio in Review

As of Q4 2016, FNY Managed Accounts held 441 positions worth $14.9M, down 87% from $118M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

FNY Managed Accounts withdrew a net $102M in Q4 2016, closing 403 positions and reducing 5 holdings. Its most notable exit was LinkedIn Corporation, an estimated $14.8M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 6.4% a quarter earlier, followed by Healthcare and Technology.

Against the trend, FNY Managed Accounts opened a new position in Tesla worth $4.27M.

  • FNY Managed Accounts's largest Q4 2016 buy was Tesla: 300,000 shares worth $4.27M.
  • FNY Managed Accounts added most to St Jude Medical in Q4 2016, an estimated $3.12M increase.
  • FNY Managed Accounts's biggest Q4 2016 reduction was Revlon, Inc., cutting an estimated $1.82M.
  • FNY Managed Accounts fully exited LinkedIn Corporation in Q4 2016, selling an estimated $14.8M.
  • FNY Managed Accounts's ten largest holdings make up 88% of its $14.9M portfolio in Q4 2016.
  • FNY Managed Accounts opened 17 new positions and closed 403 in Q4 2016.
  • FNY Managed Accounts's portfolio value fell 87% quarter-over-quarter to $14.9M.

Based on FNY Managed Accounts's 13F filing for Q4 2016, filed 8 Feb 2017.